Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia - A Single-Institution Experience

Karthik Ramasamy, Shameem Mahmood, ZiYi Lim, Sophie Corderoy, Stephen Devereux, Ghulam J. Mufti, Antonio Pagliuca, Stephen Schey

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia - A Single-Institution Experience'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology